Review Choice Demonstration and Pre-Claim Review in Medicare Home Health
- Robert Drew
- Feb 4
- 4 min read
Evidence From FY 2023 CMS Data and Implications for Agency Governance, Compliance, and Financial Sustainability
The Centers for Medicare & Medicaid Services (CMS) continues to expand prior authorization and pre-claim review programs as central mechanisms to reduce improper Medicare payments while preserving beneficiary access to medically necessary services. The Review Choice Demonstration (RCD) for Home Health Services represents a mature application of this strategy, shifting enforcement earlier in the claim’s lifecycle. This paper analyzes CMS Fiscal Year (FY) 2023 data to assess the operational, financial, and governance implications of RCD for home health agencies. Findings demonstrate that agencies achieving high pre-claim affirmation rates experience reduced administrative burden, faster payment, and lower audit exposure, while agencies with persistent non-affirmations face material financial and compliance risk.
CMS has increasingly relied on prior authorization and pre-claim review as proactive tools to combat fraud, waste, and abuse within Medicare Fee-for-Service. Unlike traditional post-payment audits, these programs evaluate documentation and coverage compliance before claims are finalized, thereby reducing downstream denials and appeals. The Review Choice Demonstration (RCD) for Home Health Services allows agencies to select among multiple review pathways, including 100 percent pre-claim review and post-payment review, until a sustained compliance threshold is achieved.
The FY 2023 CMS data provides a comprehensive opportunity to evaluate whether pre-claim review achieves its stated goals and what lessons home health agencies must internalize as these models expand.
Overview of the Review Choice Demonstration for Home Health
Under RCD, home health agencies submit documentation either before claim submission (pre-claim review) or after payment (post-payment review). Agencies remain subject to review until they demonstrate a minimum 90 percent affirmation or approval rate, at which point review intensity may be reduced, subject to spot checks.
CMS emphasizes that RCD does not introduce new coverage or documentation requirements. Rather, it requires agencies to submit the same documentation earlier in the process, reinforcing adherence to existing Conditions of Participation, medical necessity standards, and OASIS accuracy requirements.
FY 2023 Performance Results
CMS reported approximately 1.84 million pre-claim review requests for home health services in FY 2023. Of these, 97 percent received provisional affirmation. The Medicare Administrative Contractor (MAC) accuracy rate reached 100 percent, with an average review turnaround time of four days. Appeals occurred in a minority of cases; however, 35.4 percent of appealed claims were overturned at the first level, primarily due to the submission of additional documentation that had not been included in the original review package.
These data suggest that non-affirmations are less frequently the result of incorrect coverage determinations and more often reflect incomplete or inconsistent documentation at the time of submission.
Operational and Financial Implications
The FY 2023 data indicate that pre-claim review often functions as a differentiator between operationally mature/well managed agencies and those with fragmented documentation processes.
Agencies maintaining affirmation rates at or above the 90 percent threshold benefit from reduced review burden, improved cash-flow predictability, and lower administrative redoes. On the other hand, it is rarely because of contractor processing time. Instead, they are clearly driven by agency-level documentation deficiencies, reinforcing the operational importance of front-end accuracy.
Documentation Quality as a Governance Issue
Across CMS prior authorization and pre-claim review programs, including home health, hospital outpatient services, durable medical equipment companies. The most common reason for the overturning of appeal is the submission of additional documentation not provided during the initial review. This trend underscores that documentation quality is no longer solely a clinical or compliance function, it is a core financial control.
For home health agencies, documentation risk is concentrated at Start of Care and includes OASIS item accuracy, patient eligibility including homebound and physician face-to-face narratives. Of course, this must be in alignment with skilled need, care planning, and visit documentation. Failure in these areas spreads downstream into denials, appeals, and prolonged review status.
Board-Level Risk Assessment Framework
To support Board/Governing Body oversight, organizations should adopt a structured approach to measuring RCD exposure. A risk-scoring framework may include assessment of affirmation rates, documentation revision frequency, OASIS correction trends, physician documentation timeliness, denial root-cause repetition, appeal dependency, submission timeliness, and QAPI integration.
This combined scoring can stratify organizational risk as low, moderate, high, or critical, guiding targeted corrective action and resource allocation. Such tools allow Boards to monitor RCD readiness proactively rather than reacting to denials or cash-flow disruptions.
Strategic Implications and Future Outlook
The FY 2023 results strongly suggest that pre-claim review models are achieving CMS’s objectives and are likely to expand in scope or geography. Agencies who believe that RCD is a temporary demonstration will risk ongoing financial and compliance exposure. On the other hand, agencies that operationalize documentation excellence, real-time monitoring, and Board-level accountability position themselves for long-term sustainability in an increasingly controlled Medicare environment.
Conclusion
CMS FY 2023 data confirm that the Review Choice Demonstration for Home Health is not merely a fraud-prevention initiative. It is, however, a structural shift in how Medicare is enforcing compliance. Agencies investing in front-end documentation quality and governance oversight are rewarded with payment stability and reduced administrative burden. Those failing to adapt to requirements face escalating operational and financial risk. As CMS continues to emphasize pre-payment controls, RCD readiness should be regarded as a core competency of modern home health operations. Gateway can analyze RCD results on an individual provider basis and provide a risk stratification tool with follow-up documentation training.
References; Centers for Medicare & Medicaid Services. Prior Authorization and Pre-Claim Review Program Statistics for Fiscal Year 2023. Released January 17, 2025.
Robert Drew, CEO
Gateway Home Health Coding & Consulting
(248) 230-9588
Comments